| Texto completo | |
| Autor(es): Mostrar menos - |
Carvalho, Diego B.
;
Costa, Pedro A. N.
;
Portapilla, Gisele B.
;
das Neves, Amarith R.
;
Shiguemoto, Cristiane Y. K.
;
Pelizaro, Bruno I.
;
Silva, Fernanda
;
Piranda, Eliane M.
;
Arruda, Carla C. P.
;
Gaspari, Priscyla D. M.
;
Cardoso, Iara A.
;
Luccas, Pedro H.
;
Nonato, M. Cristina
;
Lopes, Norberto P.
;
de Albuquerque, Sergio
;
Baroni, Adriano C. M.
Número total de Autores: 16
|
| Tipo de documento: | Artigo Científico |
| Fonte: | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY; v. 260, p. 25-pg., 2023-09-13. |
| Resumo | |
Chagas disease and leishmaniasis are neglected diseases of high priority as a public health problem. Pharmacotherapy is based on the administration of a few drugs, which exhibit hazardous adverse effects and toxicity to the patients. Thus, the search for new antitrypanosomatid drugs is imperative to overcome the limitations of the treatments. In this work, 46 2-nitroimidazole 3,5-disubstituted isoxazole compounds were synthesized in good yields by [3 + 2] cycloaddition reaction between terminal acetylene (propargyl-2-nitroimidazole) and chloro-oximes. The compounds were non-toxic to LLC-MK2 cells. Compounds 30, 35, and 44 showed in vitro antichagasic activity, 15-fold, 12-fold, and 10-fold, respectively, more active than benznidazole (BZN). Compounds 30, 35, 44, 45, 53, and 61 acted as substrates for the TcNTR enzyme, indicating that this might be one of the mechanisms of action involved in their antiparasitic activity. Piperazine series and 4-monosubstituted com-pounds were potent against T. cruzi parasites. Besides the in vitro activity observed in compound 45, the in vivo assay showed that the compound only reduced the parasitemia levels by the seventh-day post-infection (77%, p > 0.001) compared to the control group. However, 45 significantly reduced the parasite load in cardiac tissue (p < 0.01) 11 days post-infection. Compounds 49, 52, and 54 showed antileishmanial activity against intracellular amastigotes of Leishmania (L.) amazonensis at the same range as amphotericin B. These findings highlight the antitrypanosomatid properties of 2-nitroimidazole 3,5-disubstituted isoxazole compounds and the possibility in using them as antitrypanosomatid agents in further studies. (AU) | |
| Processo FAPESP: | 16/26196-7 - Nitrorredutase de Trypanosoma cruzi: Busca por novos substratos e caracterização cinética. |
| Beneficiário: | Pedro Henrique Luccas |
| Modalidade de apoio: | Bolsas no Brasil - Iniciação Científica |